The newly discovered relevance of HB-EGF as an anti-inflammatory and tissue-protective factor in the context of autoimmune CNS inflammation may therefore not only drive the development of novel therapeutic strategies for MS, but also for other types of CNS insults, as demonstrated in a study examining neonatal white matter damage50. The gene discussed is HBEGF; the disease is myeloid sarcoma.